PRMT6 and neoplasm: Interestingly, for those samples for which we had clinical information regarding the tumour stage (n = 166), we observed positive correlation (P = 0.019) between PRMT6 up-regulation and tumour stage (Figure 1B), suggesting that more aggressive tumours might benefit from PRMT6 overexpression.